NOVAVAX INC
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 5, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | Citigroup | maintain | Sell → Sell | — | 54% |
| Jun 11, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 6, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Feb 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Jan 20, 2026 | BTIG | reiterate | Buy → Buy | $19 | 52% |
| Nov 18, 2025 | JP Morgan | maintain | Underweight → Underweight | $6 | 54% |
| Nov 10, 2025 | B. Riley Securities | reiterate | Buy → Buy | $16 | 54% |
| Nov 4, 2025 | TD Cowen | maintain | Hold → Hold | $7 | 54% |
| Oct 24, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $18 | 50% |
| Oct 23, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Aug 20, 2025 | B of A Securities | downgrade | Neutral → Underperform | $7 | 53% |
| Jul 22, 2025 | B of A Securities | maintain | Neutral → Neutral | $9 | 53% |
| Jun 17, 2025 | Citigroup | initiate | — → Sell | $6 | 54% |
| May 9, 2025 | JP Morgan | maintain | Underweight → Underweight | $7 | 54% |
| Dec 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| Aug 12, 2024 | B. Riley Securities | reiterate | Buy → Buy | $23 | 54% |
| Aug 12, 2024 | JP Morgan | maintain | Underweight → Underweight | $9 | 54% |
| Aug 2, 2024 | B. Riley Securities | maintain | Buy → Buy | $25 | 54% |
| Jul 30, 2024 | JP Morgan | downgrade | Neutral → Underweight | $8 | 54% |
| Jun 14, 2024 | B of A Securities | maintain | Neutral → Neutral | $18 | 53% |
| May 23, 2024 | B. Riley Securities | maintain | Buy → Buy | $29 | 54% |
| May 13, 2024 | TD Cowen | maintain | Hold → Hold | $10 | 54% |
| May 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $19 | 44% |
| May 10, 2024 | B of A Securities | upgrade | Underperform → Neutral | $12 | 53% |
| Mar 1, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $19 | 44% |
| Feb 23, 2024 | B. Riley Securities | maintain | Buy → Buy | $11 | 54% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Aug 9, 2023 | B. Riley Securities | upgrade | Neutral → Buy | $15 | 54% |
| May 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $35 | 44% |
| Mar 1, 2023 | B. Riley Securities | downgrade | Buy → Neutral | $10 | 54% |
| Feb 13, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $110 | 44% |
| Jan 2, 2023 | HC Wainwright & Co. | maintain | — → Buy | $110 | 44% |
| Oct 14, 2022 | B. Riley Securities | maintain | — → Buy | $83 | 54% |
| Sep 22, 2022 | JP Morgan | downgrade | Neutral → Underweight | $27 | 54% |
| Aug 9, 2022 | Cowen & Co. | maintain | — → Outperform | $110 | — |
| Jun 8, 2022 | Cantor Fitzgerald | maintain | — → Overweight | $168 | 50% |
| May 20, 2022 | B of A Securities | initiate | — → Underperform | $0 | 53% |
| Apr 26, 2022 | B. Riley Securities | maintain | — → Buy | $203 | 54% |
| Mar 3, 2022 | HC Wainwright & Co. | maintain | — → Buy | $207 | 44% |
| Jan 21, 2022 | Cowen & Co. | initiate | — → Outperform | $150 | — |
| Dec 21, 2021 | JP Morgan | maintain | — → Neutral | $209 | 54% |
| Jun 15, 2021 | Cantor Fitzgerald | maintain | — → Overweight | $272 | 50% |
| May 12, 2021 | Cantor Fitzgerald | maintain | — → Overweight | $217 | 50% |
| May 12, 2021 | HC Wainwright & Co. | maintain | — → Buy | $294 | 44% |
| May 12, 2021 | JP Morgan | downgrade | Overweight → Neutral | $161 | 54% |
| Mar 12, 2021 | HC Wainwright & Co. | maintain | — → Buy | $317 | 44% |
| Feb 18, 2021 | B. Riley Securities | maintain | — → Buy | $397 | 54% |
| Feb 5, 2021 | Cantor Fitzgerald | maintain | — → Overweight | $338 | 50% |
No cross-platform signals in the last 90 days
Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.
Subscribe for Full Access